Novel Tetrahydroquinazolinamines as Selective Histamine 3 Receptor Antagonists for the Treatment of Obesity-Reference-Cited by-同舟云学术

Novel Tetrahydroquinazolinamines as Selective Histamine 3 Receptor Antagonists for the Treatment of Obesity

Published:2019-04-18 Issue:9 Volume:62 Page:4638-4655
ISSN:0022-2623
Container-title:Journal of Medicinal Chemistry
language:en
Short-container-title:J. Med. Chem.

Author:

Kumar Ajeet,Pasam Venkata Reddy,Thakur Ravi Kumar,Singh Maninder,Singh Kartikey,Shukla Mahendra,Yadav Anubhav,Dogra Shalini,Sona Chandan¹,Umrao Deepmala,Jaiswal Swati,Ahmad Hafsa,Rashid Mamunur,Singh Sandeep K.,Wahajuddin Muhammad,Dwivedi Anil Kumar,Siddiqi Mohammad Imran¹^ORCID,Lal Jawahar,Tripathi Rama Pati¹²^ORCID,Yadav Prem N.¹^ORCID

Affiliation:

1. Academy of Scientific and Innovative Research (AcSIR), New Delhi 110001, India

2. National Institute of Pharmaceutical Education and Research Raebareli, New Transit Campus, Bijnor Road, Sarojani Nagar, Near CRPF Base Camp, Lucknow, 226002 Uttar Pradesh, India

Funder

Council??of??Scientific and Industrial Research, India

University Grants Commission

Department of Science and Technology, Ministry of Science and Technology

Publisher

American Chemical Society (ACS)

Subject

Drug Discovery,Molecular Medicine

Link

https://pubs.acs.org/doi/pdf/10.1021/acs.jmedchem.9b00241

Reference87 articles.

1. The histamine H3 receptor: from gene cloning to H3 receptor drugs